HDAC inhibitors influence several cellular regulatory processes by histone acetylation, leading to a transcription-permissive chromatin state, and by acetylation of non-histone proteins which induce apoptosis and cellular differentiation in cancer cells [13]. This evidence concerns the gene HDAC9 and cancer.